Evidence map›Paper›PMID 15925201›Full record

ArticleHearing research2005

Cytoplasmic and intra-nuclear binding of gentamicin does not require endocytosis.

Sigrid E Myrdal, Katherine C Johnson, Peter S Steyger

Abstract read
In one paragraph

Article in Hearing research, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 77 citations in OpenAlex.

  1. Drug Discovery Targeting Nicotinic Acetylcholine Receptors for Hearing Loss.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Identifying targets to prevent aminoglycoside ototoxicity.Molecular and cellular neurosciences · 2022
    Review
  6. Article
  7. Type I interferon remodels lysosome function and modifies intestinal epithelial defense.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Impact of Gentamicin Concentration and Exposure Time on IntracellularFrontiers in cellular and infection microbiology · 2017
    Article
  15. Review
  16. Rhodamine analogues for molecular ruler applications.Dyes and pigments : an international journal · 2016
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sigrid E MyrdalOregon Hearing Research Center, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.
Katherine C Johnson
Peter S Steyger
Oregon Health & Science University · US

Funding

PORTLAND AREA COMMUNICATION RESEARCH CORE CENTERP30DC005983 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI NUTTALL, ALFRED L · 2003 to 2017
$9.0M
HAIR CELL RESPONSES TO OTOTOXIC DRUGSR01DC004555 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI STEYGER, PETER STEPHEN · 2001 to 2020
$6.6M
Hair cell responses to ototoxic drugsR56DC004555 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI STEYGER, PETER STEPHEN · 2007 to 2007
$385k
Functional similarities in renal and cochlear epitheliaR21DC006084 · NIDCD · OREGON HEALTH AND SCIENCE UNIVERSITY · PI STEYGER, PETER S · 2003 to 2004
$299k
NIDCD NIH HHS DC04555NIDCD NIH HHS DC06084NIDCD NIH HHS P30 DC005983NIDCD NIH HHS R01 DC004555NIDCD NIH HHS R21 DC006084
6 · The paper itself

Abstract

Understanding the cellular mechanism(s) by which the oto- and nephrotoxic aminoglycoside antibiotics penetrate cells, and the precise intracellular distribution of these molecules, will enable identification of aminoglycoside-sensitive targets, and potential uptake blockers. Clones of two kidney cell lines, OK and MDCK, were treated with the aminoglycoside gentamicin linked to the fluorophore Texas Red (GTTR). As in earlier reports, endosomal accumulation was observed in live cells, or cells fixed with formaldehyde only. However, delipidation of fixed cells revealed GTTR fluorescence in cytoplasmic and nuclear compartments. Immunolabeling of both GTTR and unconjugated gentamicin corresponded to the cytoplasmic distribution of GTTR fluorescence. Intra-nuclear GTTR binding co-localized with labeled RNA in the nucleoli and trans-nuclear tubules. Cytoplasmic and nuclear distribution of GTTR was quenched by phosphatidylinositol-bisphosphate (PIP2), a known ligand for gentamicin. Cytoplasmic and nuclear GTTR binding increased over time (at 37 degrees C, or on ice to inhibit endocytosis), and was serially competed off by increasing concentrations of unconjugated gentamicin, i.e., GTTR binding is saturable. In contrast, little or no reduction of endocytotic GTTR uptake was observed when cells were co-incubated with up to 4 mg/mL unconjugated gentamicin. Thus, cytoplasmic and nuclear GTTR uptake is time-dependent, weakly temperature-dependent and saturable, suggesting that it occurs via an endosome-independent mechanism, implicating ion channels, transporters or pores in the plasma membrane as bioregulatory routes for gentamicin entry into cells.

Indexed as

AnimalsAnti-Bacterial AgentsBinding SitesCell LineDogsDose-Response Relationship, DrugEndocytosisFluorescent DyesGentamicinsImmunohistochemistryKidney Tubules, DistalKidney Tubules, ProximalMicroscopy, ConfocalNeuronsOpossumsPhosphatidylinositol 4,5-DiphosphateAnti-Bacterial AgentsFluorescent DyesGentamicinsPhosphatidylinositol 4,5-DiphosphateTexas redXanthenes

Identifiers

PMID15925201
PMCPMC2736065
OpenAlexW2021287373

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.